Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Estimation of Annual Exposures and Antibody Kinetics Against Norovirus GII.4 Variants from English Serology Data, 2007-2012.
O'Reilly, KM; Hay, JA; Lindesmith, L; Allen, D; Hue, S; Debbink, K; Kucharski, A; Baric, R; Breuer, J; Edmunds, WJ;
2026
openRxiv (2026). 10.64898/2026.03.09.26347737.
Kinetics of antibodies and risk of respiratory syncytial virus infection: a longitudinal cohort in Taizhou City, eastern China.
Wang, Q; Hodgson, D; Zheng, B; Liang, H; Zhang, S; Xu, J; Leung, K; KUCHARSKI, A; Lin, H; Wang, W;
2026
BMC medicine, (2026).24, 10.1186/s12916-026-04773-4.
Impact and cost-effectiveness of maternal vaccine and short and long-acting monoclonal antibodies against respiratory syncytial virus among children in Japan: A modeling study.
Kitamura, N; Kimura, T; Morino, S; Suzuki, M; Cook, AR; ABBAS, K;
2026
Vaccine: X, (2026).30, 10.1016/j.jvacx.2026.100805.
ENSO-driven temperature variability shifts the altitudinal frontier of dengue risk in the Andes.
San-José, A; Puentes, D; LOWE, R; Santos-Vega, M;
2026
bioRxiv (2026). 10.64898/2026.03.06.710067.
simulist: An R package to simulate disease outbreak line list and contacts data.
LAMBERT, JW; KUCHARSKI, AJ; Cuartero, CT;
2026
Journal of Open Source Software, (2026).11 119 10.21105/joss.08781.
Performance evaluation of an operational dengue forecasting system (D-MOSS) in Vietnam.
Campbell, AM; Colón-González, F; Quoc, DK; Tuan, NH; Dong, NT; Trang, TT; Sulaiman, LH B; Wong, SF; Hofmann, B; Tsarouchi, G; Harpham, Q; Nam, VS; BRADY, O;
2026
PLOS global public health, (2026).6 3 10.1371/journal.pgph.0005867.
Age-Specific Concentrations and Seroprevalence of Antibodies Against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) Across 3 Sites in Kenya.
Muthumbi, EM; Elias, SC; Mwanzu, A; Mutiso, A; Wanjiku, P; Mbae, C; Bigogo, G; Verani, JR; FLASCHE, S; Kariuki, S; MacLennan, CA; SCOTT, JA G;
2026
The Journal of infectious diseases, (2026).233 5 10.1093/infdis/jiag114.
Imprecision in tuberculosis infection outcomes: implications for non-inferiority vaccine trials.
GRINT, DJ; WHITE, RG; Churchyard, G; Fiore-Gartland, A; Rangaka, M; Garcia-Basteiro, AL; Cobelens, F;
2026
International journal of epidemiology, (2026).55 2 10.1093/ije/dyag034.
The epidemiological effect and cost-effectiveness of expanded age eligibility for recombinant zoster vaccination in England.
KU, C-C; Rosello, A; Walker, J; Pouwels, KB; Baguelin, M; DAVIES, NG; Jit, M;
2026
Vaccine, (2026).78, 10.1016/j.vaccine.2026.128405.
Social Mixing Patterns and Chikungunya Reemergence Risk in French Polynesia.
Chung, K-K; Aubry, M; Teiti, I; Mapotoeke, M; White, R; Bossin, H; Mathieu-Daudé, F; Dian, L; Paoaafaite, T; Wattiaux, A; Mallet, H-P; Vanhomwegen, J; Manuguerra, J-C; KUCHARSKI, A; Cao-Lormeau, V-M;
2026
JAMA network open, (2026).9 3 10.1001/jamanetworkopen.2026.2270.